124 related articles for article (PubMed ID: 28711238)
1. CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita.
Kasperkiewicz M; Kalies K; Pagel R; Bieber K; Zillikens D; Ludwig RJ
J Dermatol Sci; 2017 Nov; 88(2):248-250. PubMed ID: 28711238
[No Abstract] [Full Text] [Related]
2. Passive transfer of autoantibodies from a patient with mutilating epidermolysis bullosa acquisita induces specific alterations in the skin of neonatal mice.
Borradori L; Caldwell JB; Briggaman RA; Burr CE; Gammon WR; James WD; Yancey KB
Arch Dermatol; 1995 May; 131(5):590-5. PubMed ID: 7741548
[TBL] [Abstract][Full Text] [Related]
3. Serration pattern analysis as a tool for the diagnosis of immunoglobulin A-mediated epidermolysis bullosa acquisita.
Senatore S; Maglie R; Salemme A; Caproni M; Di Zenzo G; Antiga E
J Dermatol; 2020 May; 47(5):e198-e199. PubMed ID: 32125019
[No Abstract] [Full Text] [Related]
4. Epidermolysis bullosa acquisita: concise review and practical considerations.
Lehman JS; Camilleri MJ; Gibson LE
Int J Dermatol; 2009 Mar; 48(3):227-35; quiz 235-6. PubMed ID: 19261008
[No Abstract] [Full Text] [Related]
5. Anti-epiligrin cicatricial pemphigoid and epidermolysis bullosa acquisita: differentiation by use of indirect immunofluorescence microscopy.
Vodegel RM; de Jong MC; Pas HH; Yancey KB; Jonkman MF
J Am Acad Dermatol; 2003 Apr; 48(4):542-7. PubMed ID: 12664017
[TBL] [Abstract][Full Text] [Related]
6. Epidermolysis bullosa acquisita in a 6-year-old Japanese boy.
Hayashi K; Ueda M; Sakai M; Fujikawa Y; Tsuru K; Amagai M; Ichihashi M
Int J Dermatol; 1998 Aug; 37(8):612-4. PubMed ID: 9732011
[No Abstract] [Full Text] [Related]
7. Periorbital papulovesicular eruption in an elderly man. Localized periorbital epidermolysis bullosa acquisita (EBA).
Derrow AE; Mutasim DF
Arch Dermatol; 2009 May; 145(5):589-94. PubMed ID: 19451507
[No Abstract] [Full Text] [Related]
8. Whole-Genome Expression Profiling in Skin Reveals SYK As a Key Regulator of Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Samavedam UK; Mitschker N; Kasprick A; Bieber K; Schmidt E; Laskay T; Recke A; Goletz S; Vidarsson G; Schulze FS; Armbrust M; Schulze Dieckhoff K; Pas HH; Jonkman MF; Kalies K; Zillikens D; Gupta Y; Ibrahim SM; Ludwig RJ
Front Immunol; 2018; 9():249. PubMed ID: 29497423
[TBL] [Abstract][Full Text] [Related]
9. T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita.
Bieber K; Witte M; Sun S; Hundt JE; Kalies K; Dräger S; Kasprick A; Twelkmeyer T; Manz RA; König P; Köhl J; Zillikens D; Ludwig RJ
Sci Rep; 2016 Dec; 6():38357. PubMed ID: 27917914
[TBL] [Abstract][Full Text] [Related]
10. Radiosensitive Hematopoietic Cells Determine the Extent of Skin Inflammation in Experimental Epidermolysis Bullosa Acquisita.
Iwata H; Witte M; Samavedam UK; Gupta Y; Shimizu A; Ishiko A; Schröder T; Seeger K; Dahlke M; Rades D; Zillikens D; Ludwig RJ
J Immunol; 2015 Sep; 195(5):1945-54. PubMed ID: 26202985
[TBL] [Abstract][Full Text] [Related]
11. IgM-mediated epidermolysis bullosa acquisita.
Suchniak JM; Diaz LA; Lin MS; Fairley JA
Arch Dermatol; 2002 Oct; 138(10):1385-6. PubMed ID: 12374560
[No Abstract] [Full Text] [Related]
12. The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita.
Sadeghi H; Gupta Y; Möller S; Samavedam UK; Behnen M; Kasprick A; Bieber K; Müller S; Kalies K; de Castro Marques A; Recke A; Schmidt E; Zillikens D; Laskay T; Mariani J; Ibrahim SM; Ludwig RJ
J Pathol; 2015 Sep; 237(1):111-22. PubMed ID: 25953430
[TBL] [Abstract][Full Text] [Related]
13. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature.
Arpey CJ; Elewski BE; Moritz DK; Gammon WR
J Am Acad Dermatol; 1991 May; 24(5 Pt 1):706-14. PubMed ID: 1869641
[TBL] [Abstract][Full Text] [Related]
14. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.
Mihai S; Chiriac MT; Takahashi K; Thurman JM; Holers VM; Zillikens D; Botto M; Sitaru C
J Immunol; 2007 May; 178(10):6514-21. PubMed ID: 17475881
[TBL] [Abstract][Full Text] [Related]
15. Epidermolysis bullosa acquisita associated with psoriasis.
Kabashima R; Hino R; Bito T; Kabashima K; Nakamura M; Bungo O; Hashimoto T; Tokura Y
Acta Derm Venereol; 2010 May; 90(3):314-6. PubMed ID: 20526561
[No Abstract] [Full Text] [Related]
16. Diagnosis and clinical features of epidermolysis bullosa acquisita.
Caux F
Dermatol Clin; 2011 Jul; 29(3):485-91, x. PubMed ID: 21605816
[TBL] [Abstract][Full Text] [Related]
17. [Mucosal epidermolysis bullosa acquisita complicated by laryngeal stenosis].
Ritzmann S; Angerstein W; Neumann NJ; Megahed M
Hautarzt; 2004 Oct; 55(10):974-6. PubMed ID: 15351868
[TBL] [Abstract][Full Text] [Related]
18. Increased TREM-1 expression in inflamed skin has no functional impact on the pathogenesis of cutaneous disorders.
Dräger S; Kalies K; Sidronio TB; Witte M; Ludwig RJ; Bieber K
J Dermatol Sci; 2017 Oct; 88(1):152-155. PubMed ID: 28610717
[No Abstract] [Full Text] [Related]
19. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of epidermolysis bullosa acquisita.
Ludwig RJ; Zillikens D
Dermatol Clin; 2011 Jul; 29(3):493-501, xi. PubMed ID: 21605817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
